|

PENG Block & PENG PRF

RECRUITINGSponsored by Ankara City Hospital Bilkent
Actively Recruiting
SponsorAnkara City Hospital Bilkent
Started2026-02-01
Est. completion2027-02-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07360093

Summary

The primary aim of this study is to prospectively compare the effects of the pericapsular nerve group (PENG) block alone and the combination of PENG block with pulsed radiofrequency (PRF) on pain intensity in patients with chronic hip pain. As a secondary aim, the effects of both treatment modalities on hip function are intended to be evaluated using valid and reliable functional assessment scales. Through this study, it is aimed to demonstrate the clinical contribution of adding PRF to the PENG block and to identify a more effective and longer-lasting approach for the interventional treatment of chronic hip pain.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Presence of chronic hip pain lasting at least 3 months
* Baseline Visual Analog Scale (VAS) score ≥ 4
* Clinical and/or radiological diagnosis of hip osteoarthritis
* Inadequate response to conservative treatments

Exclusion Criteria:

* Local or systemic infection at the intervention site
* Coagulopathy or inability to discontinue anticoagulant therapy
* Hip pain related to malignancy
* History of previous hip arthroplasty
* Severe neurological deficit
* Pregnancy or breastfeeding

Conditions2

ArthritisOsteoarthritis (OA) of the Hip

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.